Shen Neil Nanpeng Abb Vie Inc. Transaction History

Shen Neil Nanpeng

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $492,892 - $583,202	-5,490 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $10,489 - $14,045	114 Added 2.12%	5,490 $520,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $481,474 - $527,976	5,376	5,376 $520,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Shen Neil Nanpeng, based on Form 13F filings with the SEC.

Stay updated on Shen Neil Nanpeng with notifications on news.